# Q3 Recap | Nucleus - Canonical URL: https://wefunder.com/feed/167646 - Entity ID: wefunder:feed_item:167646 - Published at: 2023-10-06 18:56:35 UTC - Updated at: 2025-07-09 03:23:59 UTC ## Author Logan Lenz ## Subject Nucleus ## Content Nucleus family,I am excited to share with you the latest updates on what we're doing at Nucleus along with a Q3 look back to review what we've learned. Nucleus' Ecosystem GrowthIn Q3, our user counts grew 29% across all of our companies. Nucleus (collectively): 15,838 usersNeuly: 3,320 usersPsychedelic Invest: 6,500 subscribersPsyrise: 28 usersNeuly's Soft LaunchLast week, we refreshed neuly.com with a new look, renewed purpose, and an energized model for growth. We're currently soliciting feedback and adding more data, but we would absolutely love to hear your critiques. Check your email inbox for your invites and we look forward to hearing all your thoughts and insights on what we're building.NeulyEDUWith the launch, we've unveiled access to 440 psychedelic courses. That alone might bring you pause, but what's most exciting about this progression is that we have partnered with over a dozen of these course providers to ensure NeulyEDU adds value to their enrollment processes and overall organization. You can find NeulyEDU here: https://neuly.com/coursesNeulyCAREWe've made our psychedelic-assisted therapy care directory even better with more listings, more data segments, and improved search criteria. For example, we now have a full page worth of Oregon Psilocybin listings: https://neuly.com/care?find=oregon-psilocybinNeulyRESEARCHIn an attempt to offer more data services to organizations in the psychedelics industry, we've renamed the rest of the platform NeulyRESEARCH and have established inbound workflows for research as a service and Neuly API access.NeulyRESEARCH: https://neuly.com/focusNeuly for Enterprise: https://neuly.com/enterpriseNeuly API: https://neuly.com/apiData UpdatesThe reason we soft-launched is not only to garner early feedback from any of our 3,000+ active users but to also phase in data updates we are still finalizing.This includes further updates to the following:JobsEventsClinical TrialsResearch Papers OrganizationsPeopleVisual DiagramsSearch EnhancementsWe know that the on-site search experience still needs a bit of love. We've been working on the best ways to revamp all of the search logic so that it matches Neuly's updated data structures. NeulyConciergeThe model of Neuly 2.0 is to service our users by introducing them to the partners (institutions, practitioners, organizations, etc.) via a white-glove service. That is why you'll see forms on every listing. Those forms intelligently connect directly to our partners to allow us to show how we're impacting their growth while maintaining a heightened user experience inside our platform.Wefunder Investor Access to NeulyI'd like to make sure every single one of you has access to our recently "soft-launched" Neuly platform.That is why you will be receiving your individual invite emails shortly. You will have full access to all gated (paid) content. Psychedelic Invest UpdatesI'd like to start by sharing the updated industry chart that we keep a close eye on. It doesn't take long to see the obvious 2023 decline that websites in this industry have experienced. Despite this, Psychedelic Invest has only dipped slightly and has managed to grow subscribership in Q3 by over 30%. So, yes, psychedelics are still on the rise. It's just apparent that not as many people are searching for information about them as there were in 2021 and 2022.Educating Through Content CreationIn Q3, we published the majority of our written and long-form content on Psychedelic Invest. This mostly included our researched articles and press releases but we also facilitated a handful of interviews as well. Below is a complete list of all published content in Q3.Press Releases: 173Original Articles and Events (34):https://psychedelicinvest.com/treat-nicotine-addiction-with-magic-mushrooms/https://psychedelicinvest.com/how-crowdfunding-isfueling-growth-in-the-psychedelic-industry/https://psychedelicinvest.com/psychedelics-and-artificial-intelligence/https://psychedelicinvest.com/the-science-on-psychedelics-and-ssris/https://psychedelicinvest.com/psychedelic-science-advancement-with-kernel-flow/https://psychedelicinvest.com/treating-anorexia-with-psychedelics/https://psychedelicinvest.com/cybin-raises-capital-with-public-offering/https://psychedelicinvest.com/braxia-scientific-financial-report-analysis/https://psychedelicinvest.com/atai-life-sciences-state-of-the-company/https://psychedelicinvest.com/psychedelic-legalization-is-happening-here/https://psychedelicinvest.com/compass-pathways-q2-financial-analysis/https://psychedelicinvest.com/lusaris-therapeutics-from-promising-psychedelic-startu-to-vanishing-act/https://psychedelicinvest.com/should-psychedelic-therapists-do-psychedelics/https://psychedelicinvest.com/top-10-psychedelic-companies-that-should-be-on-your-radar/https://psychedelicinvest.com/cybin-financial-analysis-q1-2023/https://psychedelicinvest.com/decriminalize-nature-president-steps-down/https://psychedelicinvest.com/psychedelic-education-is-adapting-to-meet-the-needs-of-the-modern-psychedelic-industry/https://psychedelicinvest.com/consolidation-continues-in-the-psychedelic-industry/https://psychedelicinvest.com/lucy-scientific-discovery-navigating-growth-and-diversification-in-the-psychedelic-industry/https://psychedelicinvest.com/maps-phase-iii-trial-results-mark-a-paradigm-shift-in-mental-health/https://psychedelicinvest.com/psychedelic-laws-in-vermont/https://psychedelicinvest.com/interview-with-psychedelic-athlete-ian-mccall/https://psychedelicinvest.com/psychedelic-search-trends-and-traffic-analysis-q3/https://psychedelicinvest.com/psychedelics-aliens-fiction-vs-facts/Industry Reports:https://psychedelicinvest.com/breaking-boundaries-transforming-markets-a-comprehensive-mid-year-review-of-the-psychedelic-sector-pro-report/Psychedelic Invest Podcast:https://psychedelicinvest.com/carina-cunha-helps-you-find-the-right-psychedelic-experiences-podcast-episode-31/https://psychedelicinvest.com/samuel-becht-monitors-the-progress-of-proper-dosing-podcast-episode-32/https://psychedelicinvest.com/fraser-johnston-inspires-healthy-and-cooperative-communities-podcast-episode-33/https://psychedelicinvest.com/melissa-lavasani-advocates-for-psychedelic-medicines-podcast-episode-34/Upcoming Marketing Plans and EventsWe have yet to fully launch the new Neuly.com to the public, but when we do, we want to be well-positioned to spread the word as much as possible. Here's a list of releases and events you can expect to see from us during the 4th quarter:Publish industry Q3 report on October 16th. Infographic of EDU landscape shared amongst our networks (virality) on October 16th.Our writer, Charley will begin publishing Nucleus ecosystem content on October 16th.Press Release announcement scheduled for release October 17th.Email Blast is scheduled for October 18th. CEO Logan Lenz is slated to host a live webinar/demo on October 19th.Neuly to begin sharing updated data widgets on October 25th.EDU Webinar with ReMind on October 26th.EDU sector webinar with Psy-Ins in November.Release/announce updated Neuly Research data in November.Wonderland conference party/appearance in Miami on November 9-11.Table/sponsorship appearance at ReMind conference in Las Vegas on November 28-29.Psyrise UpdatesWe made some significant feature updates to Psyrise in Q3. First of all, check out the flashy new dashboard. We also added community management tools and a conversational AI tool. Presently, we have 8 paying clinics using Psyrise on a regular basis. We are still assessing our timeline and looking into ways we can accelerate the sales process soon. In terms of effectiveness, one clinic generated $171,500 in lead flow through Psyrise during Q2.Coming Soon: Data PartnershipIt's still early, but we're building a formal partnership with a data warehouse that will allow us to level up our market and customer intelligence. I don't want to give away too much too soon, but I expect to have many more capabilities on the servicing and infrastructural side of Neuly that we'll be able to roll out in January 2024.Shirt SizesAll Wefunder investors - please fill out the below form so we can send you your Nucleus t-shirts!https://airtable.com/appIwHUbqWE2XkKwr/shrqi12stPpwLSBUiThank YouThank you so much for your continued support. We will continue to navigate the current market conditions and proceed as frugally and responsibly as possible. While our short-term plan is to accelerate revenue growth, our long-term plan is to hold as much cash on hand as possible so that our current funds can last well into 2025.As always, please reach out to me at logan@withnucleus.com if you ever have any questions, concerns, or ideas.Here's to an amazing Q4!Now let's go change the world!